Sahid Khudiram Bose Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.43 M
as on 24-10-2024
- Revenue 18.93%
(FY 2023)
- Profit 104.81%
(FY 2023)
- Ebitda 34.26%
(FY 2023)
- Net Worth 39.41%
(FY 2023)
- Total Assets 1.17%
(FY 2023)
About Sahid Khudiram Bose Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.64 Cr.
Ashis Saha, Govinda Ganguly, Subrata Dasgupta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85100WB2014NPL201355
- Company No.
201355
- Company Classification
Private Not For Profit Company
- Incorporation Date
25 Mar 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sahid Khudiram Bose Hospital?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Suprieo Bhadra | Director | 19-Feb-2022 | Current |
Ashis Saha | Director | 25-Mar-2014 | Current |
Govinda Ganguly | Director | 25-Mar-2014 | Current |
Subrata Dasgupta | Director | 25-Mar-2014 | Current |
Hemanta Ray | Director | 31-Dec-2016 | Current |
Financial Performance and Corporate Structure Insights of Sahid Khudiram Bose Hospital.
Sahid Khudiram Bose Hospital, for the financial year ended 2023, experienced significant growth in revenue, with a 18.93% increase. The company also saw a substantial improvement in profitability, with a 104.81% increase in profit. The company's net worth Soared by an impressive increase of 39.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sahid Khudiram Bose Hospital?
In 2020, Sahid Khudiram Bose Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
North Twenty Four Parganas Chamber Of Commerece Industry
Active 5 years 2 monthsAshis Saha is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 05 Mar 2024 | ₹2.45 M | Open |
Others Creation Date: 29 Mar 2018 | ₹0.88 M | Open |
Others Creation Date: 27 Sep 2017 | ₹2.40 M | Open |
How Many Employees Work at Sahid Khudiram Bose Hospital?
Sahid Khudiram Bose Hospital has a workforce of 154 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahid Khudiram Bose Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahid Khudiram Bose Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.